Our HTS services have evolved from routine HIV testing and counseling at the health facilities at the height of the HIV epidemic to differentiated service delivery models both at the health facility and the community levels using a patient-centered approach. For instance, using our Assisted Partner Notification (APN) model, we reach the partners of our consenting clients and encourage them to test for HIV. Our clinic hours are flexible to cater to people who work 5-8 jobs.

HIV Care & Treatment
Through our HIV Care and Treatment program, we provide high quality, cost-effective services that promote access to and ongoing success in HIV treatment for people with HIV/AIDS. With successful case management, access to important support services and assistance through MJAP’s care program, people living with HIV/AIDS (PLHIV) are empowered to effectively manage HIV and improve their overall health and quality of life.

• To contribute to the national response, MJAP supports the provision of HIV care in several health units/clinics namely: Mulago ISS clinic, Mulago TB/HIV clinic, Kiruddu Communicable Diseases (CDC) clinic, and Butabika National Referral Hospital.

• The interventions supported by the program include management of the opportunistic infections (OIs) including TB, cervical cancer screening and family planning services for women, and child survival interventions for children.

Antiretroviral Treatment (ART)

• The ART services supported by MJAP include screening for ART eligibility, provision of ARV drugs, laboratory and clinical monitoring of ART and training of health care providers in ART services.

• To reduce losses to follow up, we have a patient tracking and adherence program for patients on ART whereby patients who miss their clinic appointments are actively followed up through phone calls and home visits.
As a result, we have had good retention on ART, CD4 assessment for all clients in care is routinely done every six (6) months.

Viral load monitoring

• MJAP has continued to implement quality improvement for viral load and results utilization. The overall viral load testing coverage for MJAP supported sites stands at 87% and viral suppression at 96%.

• Working with IDI and Uganda Ministry of Health, MJAP has trained and mentored health workers in viral load monitoring and strategies for viral suppression using continuous quality improvement methods. This has improved viral testing at 6 months after ART initiation.

• MJAP facilitates a forum for caretakers of children with viral non-suppression in a bid to improve ART treatment outcomes among children and adolescents under our care. The participants are empowered with knowledge on viral load monitoring and implications of non-suppression.